The result showed that U50A consistently downregulates SMC5, ATRX, CENPE, and CENPF, indicating a widespread phenomenon that these genes are downstream targets of U50A in breast cancer (Figure 3B). The gene discussed is SMC5; the disease is breast carcinoma.